TXG today
$59.10-$2.95 (-4.75%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourStrong Bearish
15 minBullish
5 minBearish
Daily trend turns up above $87.82
Key levels
Resistance$71.00
Resistance$61.24
Support$45.21
Support$35.12
Latest news & SEC filings
AnalystStephens starts coverage of 10x Genomics with Hold rating
Product10x Genomics says Xenium platform used in breast cancer biomarker study
DealFudan University Shanghai Cancer Center to use 10x Genomics' Xenium system in 24-month trial
NewsTorex Resources shares to begin trading on NYSE
AnalystJP Morgan keeps Neutral rating on 10x Genomics, cuts target to $65
All TXG news →About 10x Genomics
10x Genomics is a life sciences technology company that sells laboratory tools and related software for studying biology at the level of individual cells and within tissue. Its offerings include the Chromium platform for single-cell work, Visium for spatial analysis, and Xenium for in situ analysis, plus data analysis programs such as Cell Ranger and Loupe Browser. Buyers are mainly academic, government, biopharmaceutical, and biotechnology researchers, and the company sells worldwide through its own sales team and distributors.
Based on the company's 10-K filed Feb 13, 2026.
Nasdaq · Technology
10x Genomics, Inc. (TXG)
What Is the Price Target for TXG?
SEPT Low Target
$50.00
SEPT Mid Target
$70.00
SEPT High Target
$110.00
Analyst Consensus
$70.00
Is TXG a Buy or Sell Right Now?
Thesis
- •Revenue growing 5.2% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TXG.
Start Free Trial →Is TXG Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$57.07
38
Moat Score
NONE
4/9
Piotroski Score
18.2
Altman Z-Score
What Is Smart Money Doing with TXG?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SULIMAN SHEHNAAZ | director | Sale | 292 | $23K | Sep 22, 2026 |
| SULIMAN SHEHNAAZ | director | Sale | 614 | $49K | Sep 22, 2026 |
| SULIMAN SHEHNAAZ | director | Sale | 1,325 | $107K | Sep 22, 2026 |
| SULIMAN SHEHNAAZ | director | Sale | 2,270 | $185K | Sep 22, 2026 |
| SULIMAN SHEHNAAZ | director | Sale | 1,222 | $101K | Sep 22, 2026 |
| Saxonov Serge | director officer | Sale | 1,000 | $78K | Sep 22, 2026 |
| Saxonov Serge | director officer | Sale | 2,000 | $159K | Sep 22, 2026 |
| Saxonov Serge | director officer | Sale | 9,300 | $752K | Sep 22, 2026 |
| Saxonov Serge | director officer | Sale | 9,900 | $810K | Sep 22, 2026 |
| Saxonov Serge | director officer | Sale | 2,800 | $231K | Sep 22, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TXG Growth Story
Revenue YoY
5.3%
3yr Revenue CAGR
7.6%
EPS Growth YoY
76.97%
FCF Growth YoY
2371.2%
Revenue Trend
STABLE
Dark Pool Trades for TXG
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TXG, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:06:35 | $59.47 | 4,500 | $$268K | SELL |
| 22:46:06 | $59.47 | 3,600 | $$214K | BUY |
| 21:31:13 | $59.10 | 2,357 | $$139K | SELL |
| 21:04:20 | $59.10 | 4,947 | $$292K | SELL |
| 20:59:53 | $59.19 | 1,500 | $$89K | SELL |
5 dark pool trades shown · $$1.0M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TXG
PREVIEWSEPT Investing provides real-time options flow tracking for TXG, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $75 | Nov 20 | 8 | $$200 | 8 | SWEEP |
| CALL | $55 | Nov 20 | 8 | $$322 | 1 | SWEEP |
| PUT | $45 | Feb 19 | 99 | $$450 | 1 | SWEEP |
3 options trades shown · 67% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for 10x Genomics, Inc. (TXG) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TXG — frequently asked questions
What is TXG stock price today?
10x Genomics, Inc. (TXG) is at $59.10, down 4.75% (-$2.95) at the Nov 12, 2026 close.
Why is TXG stock moving today?
Latest TXG news — Nov 11, 2026: Stephens starts coverage of 10x Genomics with Hold rating · Nov 10, 2026: 10x Genomics says Xenium platform used in breast cancer biomarker study
What is the TXG price target?
The average analyst price target for TXG is $70.00, ranging from $50 to $110, based on 15 analysts. Latest: Barclays maintains on Nov 9, 2026.
What do analysts rate TXG?
Analyst ratings for TXG: 1 Buy, 35 Hold, 1 Sell — consensus Hold.
Did TXG beat earnings?
TXG last reported on Nov 5, 2026: EPS -$0.15 vs -$0.27 expected — a beat of 43.8%.
Does TXG pay a dividend?
TXG does not currently pay a dividend.
What are TXG support and resistance levels?
Support: $45.21, $35.12, $23.03. Resistance: $61.24, $71.00, $87.82.
What are insiders doing with TXG?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on TXG?
Nov 11, 2026: Stephens starts coverage of 10x Genomics with Hold rating · Nov 10, 2026: 10x Genomics says Xenium platform used in breast cancer biomarker study · Nov 10, 2026: Fudan University Shanghai Cancer Center to use 10x Genomics' Xenium system in 24-month trial